The Medicines Company Competitors and Similar CompaniesClear all
The Medicines Company's competitors and similar companies include UCB, Livzon Pharmaceutical Group, Alembic Pharmaceuticals and Genentech.
 UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions. |  Livzon Pharmaceutical Group Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products. |  Alembic Pharmaceuticals Alembic Pharmaceuticals is a company that develops, manufactures, and markets pharmaceutical products, pharmaceutical substances, and intermediates |  Genentech Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines. | ||
Founding Date | Founding Date 1996 | Founding Date 1928 | Founding Date 1985 | Founding Date 2010 | Founding Date 1976 |
Type | Type Public | Type Public | Type Public | Type Public | Type Subsidiary |
Tags | |||||
Locations | Locations Parsippany-Troy Hills, US HQ | Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more | Locations Zhuhai, CN HQ Chengdu, CN Qingyuan, CN Shanghai, CN Shaoguan, CN Shenzhen, CN Zhuhai, CN | Locations Vadodara, IN HQ Baska, IN Mumbai, IN Namthang, IN Vadodara, IN Vadodara, IN | Locations South San Francisco, US HQ Hillsboro, US Oceanside, US Portland, US South San Francisco, US South San Francisco, US South San Francisco, US see more |
Employees | Employees 6264% decrease | Employees 9,052 | Employees 9,067 | Employees 14,858 | Employees 18,077 |
Valuation ($) | Valuation ($) 6.8 b | Valuation ($) 34.3 b | Valuation ($) 4.2 b | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $6.1m (FY, 2018) | Revenue (est.) €7.4b (FY, 2025) | Revenue (est.) ¥11.7b (FY, 2025) | Revenue (est.) ₹73.4b (FY, 2026) | Revenue (est.) N/A |
Cost of goods | Cost of goods $7.3m (FY, 2018) | Cost of goods €1.4b (FY, 2025) | Cost of goods ¥4.1b (FY, 2025) | Cost of goods ₹19.8b (FY, 2026) | Cost of goods N/A |
Gross profit | Gross profit ($1.1m) (FY, 2018) | Gross profit €7.2b (FY, 2025) | Gross profit ¥7.8b (FY, 2025) | Gross profit ₹54.1b (FY, 2026) | Gross profit N/A |
Net income | Net income ($123.2m) (FY, 2018) | Net income €1.6b (FY, 2025) | Net income ¥2.4b (FY, 2025) | Net income ₹6.7b (FY, 2026) | Net income N/A |
For sources of this data, please see the company profile
View Company Profiles
UCB
HQ
Brussels, BE
Employees
9,052
UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
View companyLivzon Pharmaceutical Group
HQ
Zhuhai, CN
Employees
9,067
Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products.
View companyAlembic Pharmaceuticals
HQ
Vadodara, IN
Employees
14,858
Alembic Pharmaceuticals is a company that develops, manufactures, and markets pharmaceutical products, pharmaceutical substances, and intermediates
View companyGenentech
HQ
South San Francisco, US
Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines.
View company